KRAS and lung cancer: To further investigate the S100A10 levels in clinically relevant cancer cell lines, we depleted KRAS from A549 (lung cancer) and MiaPaca2 (pancreatic cancer) cells and analysed S100A10 expression by western blotting (Supplementary Figure S6A, S6B).